In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI-Designated Cancer Centers

Page Options

  • Print This Page
  • Email This Document

Popular Resources

Fred Hutchinson/University of Washington Cancer Consortium
Comprehensive Cancer Center

Lawrence Corey, M.D.
President & Director

P.O. Box 19024, D1-060
Seattle, Washington 98109
SCCA - New Patients/Intake: (206) 288-1024
SCCA Main: (206) 288-7222
Toll Free: 1-800-804-8824

Visit Website

Fred Hutchinson/University of Washington Cancer Consortium
Seattle, Washington

The Fred Hutchinson/University of Washington Cancer Consortium is a research collaboration comprising Fred Hutchinson Cancer Research Center and its collaborators, the University of Washington, Seattle Children’s, and the Seattle Cancer Care Alliance (SCCA). Founded in 1972, the Center received its NCI comprehensive center designation in 1976, which was expanded to include the entire Consortium in 2003.

By bringing together faculty with research interests in basic, clinical, and public health sciences related to cancer, the Consortium conducts research across many types of cancer to accelerate scientific progress. The faculty in the Consortium is organized into 13 research programs, with emphases on: public health (biostatistics, cancer prevention, and epidemiology); clinical research (clinical transplantation and transplantation biology); fundamental sciences (basic science, genome instability, stem/progenitor cell biology); and programs that impact all three disciplines (cancer imaging, gastrointestinal cancer etiology, risk, and detection, immunology and vaccine development, prostate cancer, and women’s cancers).

In addition, the Consortium is developing programs in computational biology, molecular diagnostics, pediatric oncology, and viral pathogenesis. There are also three affinity groups in neuro-oncology, thoracic/head and neck, and behavioral and outcomes research.

One focus of particular significance is the Hutchinson Center’s work on immunotherapy, starting with bone marrow transplantation. Consortium researchers are developing novel approaches to harness immunotherapy to treat leukemia and other cancers. The Consortium is expanding this work into treatment of more common solid tumors such as melanoma, breast, prostate, colon, kidney, and ovarian cancer.

The Consortium has an active program of clinical trials, with more than 500 clinical studies active at any one time, investigating the safety and efficacy of new methods of diagnosis, treatment, preventive, and supportive care.

Research-based outreach by the Consortium to underserved communities takes several forms. In the Asian American community, the Consortium focuses on community development and health education. A collaboration with New Mexico State University focuses on increasing minority engagement in cancer research. The Hutchinson Center’s collaboration with the Seattle Cancer Care Alliance emphasizes activities related to cancer prevention and survivorship.

* This profile was provided by the Fred Hutchinson/University of Washington Cancer Consortium.